Market Research Logo

The U.S. Market for Prescription Dermatological Drugs

Despite generic and over-the-counter competition, the market for prescription dermatological products offers some significant sales opportunities. This Kalorama report describes U.S. revenues and growth rate trends for anti-acne, anti-aging, anti-fungal, hair loss, topical corticosteroids and other nonsteroidal prescription dermatological drugs for the period from 1994 through 2004. Even as consumer demand is driving a strong global over-the-counter skin care market, competitive strategies are being planned and implemented by pharmaceutical industry participants, large and small. The role of biotechnology in the development of new drug delivery systems and genetic-based interventions is now of increasing importance. An infusion of novel treatments is especially needed for inadequately served populations such as individuals with dermatitis, eczema and psoriasis. Responsiveness to the demographic and market factors described in this report is a key component for future success.


Scope and Methodology

For this report, the drugs covered in this market have been divided into the following six segments:

  • Antiacne drugs;
  • Antiaging/photodamage drugs;
  • Antifungals;
  • Hair-loss drugs;
  • Topical corticosteroids; and
  • Other nonsteroidal dermatological drugs.
This report focuses on the U.S. prescription dermatological market and presents estimates of historical, current, and future revenues and growth rates for individual product segments. The analysis is based on a combination of company, government, and industry sources, with an extensive review of the literature and interviews conducted with participants (such as trade organization representatives and product managers) for additional insights. Branded and generic drugs are included within the markets covered here. Other factors are also addressed, including the role of the Internet and the product development pipeline.

Issues Addressed:

  • Current and Projected Market Growth
  • Factors Affecting Market Growth
  • Technological Advancements
  • Consumer Demographics
  • Cosmeceuticals
  • Generic and OTC Competition
  • Alternative Therapies
  • Out-of-Pocket Payment & Reimbursement
  • Industry Consolidation vs. Niche Marketing
  • R&D
  • Legislative Issues

Companies/Sites Discussed:

  • Advanced Polymer Systems
  • Allergan
  • Aventis
  • Bristol-Myers Squibb
  • Galderma
  • Glaxo SmithKline
  • Johnson & Johnson
  • Medicis
  • Merck
  • Mylan
  • Novartis
  • Roche Holding
  • Schering-Plough
  • Watson

Tables and Graphs:

  • U.S. Derm Drug Market 1995 - 2004
  • Share of Market by Category 1995 - 2004
  • Derm Drugs by Manufacturer, Category
  • Number of U.S. Skin Disorders by Age
  • Leading Suppliers’ Share of Market

Categories Covered:

  • Skin Disorders
    • Acne
    • Aging and Photodamage
    • Dermatitis and Eczema
    • Fungal Infections
    • Hair Loss
    • Psoriasis
  • Dermatological Drugs
    • Antiacne
    • Antiaging
    • Antifungals
    • Hair Loss
    • Topical Corticosteroids
    • Other Nonsteroidals

Hours of Research: 700

Chapter One


    Executive Summary
    Intro
    Scope And Methodology
    Size And Growth Of The Market
    Trends Affecting The Market
    Industry Structure And Leading Competitors
    The Consumer

Chapter Two


    Introduction
    Over
    Dermatological Conditions
    • Acne
    • Aging And Photodamage
    • Dermatitis And Eczema
    • Fungal Infections
    • Hair Loss
    • Pso

    Dermatological Drugs
    • Antiacne Drugs
    • Antibiotics
    • Oral Contraceptives
    • Retinoids
    • Other Medications
    • Antiaging/Photodamage Drugs
    • Antifungals
    • Hair-Loss Drugs
    • Topical Corticosteroids
    • Other Nonsteroidal Dermatological Drugs

    Competitive Analysis And Industry Structure
    Products In Development

Chapter Three


    Antiacne Drugs
    Overview
    Companies And Products
    • An 48
    • Benzoyl Peroxide And Combination Products
    • Retinoids
    • Oral Contraceptives And Other Products

    Current And Future Technologies
    Market Size And Forecast
    • An
    • Benzoyl Peroxide And Combination Products
    • Retinoids
    • Oral Contraceptives And Other Drugs

    Competitor Analysis
    • An
    • Benzoyl Peroxide And Combination Products
    • Retinoids
    • Oral Contraceptives And Other Antiacne Drugs

    Market Analysis

Chapter Four


    Antifungals
    Overview
    Companies And Products
    Current And Future Technologies
    Market Size And Forecast
    Competitor Analysis
    Market Analysis

Chapter Five


    Hair-Loss Drugs
    Overview
    Companies And Products
    Current And Future Technologies
    Market Size And Forecast
    Competitor Analysis
    Market Analysis

Chapter Six


    Antiaging/Photodamage Drugs
    Ov
    Companies And Products
    • Keratolytics
    • Moisturizers
    • Sunscreens
    • Depigmenting And Other Agents

    Current And Future Technologies
    Market Size And Forecast
    • Keratolytics
    • Moisturizers
    • Sunscreens
    • Depigmenting And Other Agents

    Competitor Analysis
    • Keratolytics
    • Moisturizers
    • Sunscreens
    • Depigmenting And Other Agents

    Market Analysis

Chapter Seven


    Topical Corticosteroids
    Ov
    Companies And Products
    Current And Future Technologies
    Market Size And Forecast
    Competitor Analysis
    Market Analysis

Chapter Eight


    Other Nonsteroidal Dermatological Drugs
    Overview
    Companies And Products
    • Antipruritic Drugs
    • Antiseborrheic Drugs
    • Antipsoriatic Drugs

    Current And Future Technologies
    Market Size And Forecast
    Competitor Analysis
    Market Analysis

Chapter Nine


    Issues And Trends
    Consumer Demand And Demographics
    Dermatological Visits To Physicians' Offices
    Cosmeceuticals
    Generic Competition
    Over-The-Counter Competition
    Rx-To-OTC Switches
    Alternative Dermatological Therapies
    Out-Of-Pocket Payment And Reimbursement
    Industry Consolidation Versus Niche Marketing
    Research And Development
    The Regulatory Climate

Chapter Ten


    Market Summary
    Overview Of Product Segments
    Market Size And Forecast
    Market Analysis

Chapter Eleven


    Competitor Profiles
    Advanced Polymer Systems Inc
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Allergan Inc.
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Aventis SA
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Bristol-Myers Squibb Company
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Galderma Laboratories Inc.
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Glaxo Smithkline*
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Roche Holding Ltd
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Johnson & Johnson
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Medicis Pharmaceutical Corporation
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Merck & Company Inc.
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Mylan Laboratories Inc.
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Novartis
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Schering-Plough Corporation
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

    Watson Pharmaceuticals Inc
    • History And Lines Of Business
    • Dermatological Drugs
    • Financial Information
    • Corporate Strategies

Appendix

Company Names And Addresses

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report